Zebinix non-inferior to current standard of care in epilepsy

2nd February 2018 Uncategorised 0

Eisai and Bial’s epilepsy drug Zebinix has shown effectiveness on par with that of the current standard of care in newly diagnosed focal epilepsy patients.

More: Zebinix non-inferior to current standard of care in epilepsy
Source: News